Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Huayu Jiedu Formula (FTFY-919) Granules in Acute Hypertensive Intracerebral Hemorrhage
NCT07801599Phase 3Not yet recruiting
- Sponsor
- Guangzhou University of Chinese Medicine
- Start
- Sep 2026
- Primary completion
- Nov 2027
01
Overview
A Phase 3 trial of Huayu Jiedu Formula in intracerebral hemorrhage (ICH), sponsored by Guangzhou University of Chinese Medicine. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
Huayu Jiedu Formula
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on NCT07801599.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07801599.